首页 | 本学科首页   官方微博 | 高级检索  
检索        

下咽癌颈淋巴转移相关因素的研究
引用本文:郭星,史艳春,费声重,潘子民.下咽癌颈淋巴转移相关因素的研究[J].中华耳鼻咽喉头颈外科杂志,2005,40(10):779-783.
作者姓名:郭星  史艳春  费声重  潘子民
作者单位:[1]中国医科大学附属第一医院耳鼻咽喉科,沈阳110001 [2]辽阳市第三医院耳鼻咽喉科,沈阳110001
摘    要:目的研究下咽癌颈淋巴转移的特点、规律及对预后的影响。方法收集1985-2000年住院治疗下咽癌患者108例,均经手术治疗,且术前未行放疗和化疗。根据1992年国际抗癌联合会(UICC)分期标准进行分期分级。手术后将下咽癌及颈淋巴结标本进行病理观察,确定肿瘤主体所在原发部位及发生转移的颈淋巴结分布区域。按照病理学将肿瘤的病理分化程度确定为高、中、低分化。通过颈淋巴结病理检查和随访观察确定颈淋巴转移情况,用Kaplan-Meier方法对3、5年生存率进行非参数分析。结果病例中T1、T2淋巴结转移率为45.8%,T3、T4淋巴结转移率为79.8%,总的淋巴结转移率为75.0%(81/108),(P〈0.05)。梨状窝癌为100例,占全部病例的92.6%(100/108),梨状窝及下咽后壁癌的颈淋巴转移率分别为74.0%和87.5%(P〉0.05)。病理高、中、低分化型3组,其颈淋巴转移率分别为72.2%、67.6%、85.7%(P〉0.05)。患者3、5年累积生存率分为67.53%及29.87%。Ⅱ、Ⅲ区颈淋巴转移率为76.5%,Ⅴ、Ⅵ区颈淋巴转移率为8.6%。结论下咽癌颈淋巴转移率高。下咽癌颈淋巴转移是影响下咽癌的预后主要因素,随着颈淋巴转移程度的增加,患者3、5年生存率逐渐降低。

关 键 词:下咽肿瘤  淋巴转移  预后  存活率  颈淋巴转移  下咽癌  淋巴结转移率  淋巴转移率  5年生存率  病理观察
收稿时间:2005-01-25
修稿时间:2005年1月25日

Cervical lymph node metastasis of hypopharyngeal carcinoma
Guo Xing;Shi YanChun;Fei ShengChong;Pan ZiMin.Cervical lymph node metastasis of hypopharyngeal carcinoma[J].Chinese JOurnal of Otorhinolaryngology Head and Neck Surgery,2005,40(10):779-783.
Authors:Guo Xing;Shi YanChun;Fei ShengChong;Pan ZiMin
Institution:Department of Otorhinolaryngology, First Affiliated Hospital, China Medical University, Shenyang 110001, China. guoxing1958@sina.com
Abstract:OBJECTIVE: To investigate the characteristic of cervical lymph node metastasis of hypopharyngeal carcinoma and its influence to the prognosis. METHODS: One hundred and eight hypopharyngeal carcinoma patients who accepted treatments in the 1st Affiliated Hospital of China Medical University from 1985 to 2000 were reviewed retrospectively. All of them accepted surgical treatment without pre-operative chemotherapy or radiotherapy. Stage was made according to the standard of International Union Against Cancer (UICC) in 1992. Specimens of the patients were carefully examined to confirm the primary site of the tumor and the distribution of cervical lymph node metastasis. Pathological differentiations of the tumor were classified into high, middle and low category. Kaplan-Meier method was used to estimate the 3rd, 5th years survival. RESULTS: The rates of lymph node metastasis of was 45.8% for patients with TI and T2 disease, 79.8% for those with T3 and T4, and 75.0% (81/108)for the whole patients(P < 0.05). Patients with pyriform sinus cancer occupied 92.6% (100/108) of all the cases. Cervical lymph node metastasis rate of pyriform sinus cancer and posterior pharyngeal wall cancer were 74. 0% and 87. 5% respectively (P > 0.05). Cervical lymph node metastasis rate of patients with the high, middle and low differentiation tumor were 72. 2% , 67.6% and 85.7% respectively (P > 0.05). The 3rd and 5th years survival rates of all patients were 67.53% and 29.87% respectively. The occurrence of cervical lymph node metastasis was 76.5% in the level II and III, and 8.6% in the level V and VI. CONCLUSIONS Cervical lymph node metastasis rate of hypopharyngeal carcinoma is high. Cervical lymph node metastasi was one of the most significant prognostic factors of hypopharyngeal carcinoma. With the increase of the cervical node metastasis, the 3rd and 5th years survival of the patients declined gradually.
Keywords:Hypopharyngeal neoplasms  Lymphatic metastasis  Prognosis  Survival rate
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号